Reply: Clinical trial registry alone is not adequate: On the perception of possible endpoint switching and P-hacking
File(s)FINAL Reply to letter.pdf (115.83 KB)
Accepted version
Author(s)
Type
Journal Article
Date Issued
2018-02-01
Date Acceptance
2017-11-13
Citation
Human Reproduction, 2018, 33 (2), pp.342-344
ISSN
1460-2350
Publisher
Oxford University Press (OUP)
Start Page
342
End Page
344
Journal / Book Title
Human Reproduction
Volume
33
Issue
2
Copyright Statement
© 2017 The Author. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. This is a pre-copy-editing, author-produced version of an article accepted for publication in Human Reproduction following peer review. The definitive publisher-authenticated version Ali Abbara, Sophie Clarke, Rumana Islam, Julia K Prague, Alexander Comninos, Shakunthala Narayanaswamy, Deborah A Papadopoulou, Rachel E Roberts, Chioma N Izzi-Engbeaya, Risheka Ratnasabapathy, Alexander Nesbitt, Sunitha Vimalesvaran, Rehan Salim, Stuart A Lavery, Stephen R Bloom, Les Huson, Geoffrey H Trew, Waljit S Dhillo, Reply: Clinical trial registry alone is not adequate: on the perception of possible endpoint switching and P-hacking, Human Reproduction, Volume 33, Issue 2, February 2018, Pages 342–344, is available online at: https://doi.org/10.1093/humrep/dex360
Sponsor
National Institute for Health Research
National Institute for Health Research
National Institute for Health Research
Medical Research Council (MRC)
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424139800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
CDF-2009-02-05
NF-SI-0507-10337
NF-SI-0513-10080
MR/M004171/1
Subjects
Science & Technology
Life Sciences & Biomedicine
Obstetrics & Gynecology
Reproductive Biology
OVARIAN HYPERSTIMULATION SYNDROME
HUMAN CHORIONIC-GONADOTROPIN
IN-VITRO FERTILIZATION
OOCYTE MATURATION
HIGH-RISK
KISSPEPTIN-54
WOMEN
AGONIST
Publication Status
Published
Date Publish Online
2017-11-29